{"completed suicide": 11.55, "drug interaction": 6.65, "extrapyramidal disorder": 76.36, "neuroleptic malignant syndrome": 59.03, "product use in unapproved indication": 3.1, "psychiatric symptom": 86.34, "psychotic disorder": 28.17, "restlessness": 8.9, "rhabdomyolysis": 12.0, "schizophrenia": 107.32, "suicidal ideation": 5.17, "weight increased": 8.48}